Chemistry: molecular biology and microbiology – Vector – per se
Patent
1995-06-07
1999-11-16
Degen, Nancy
Chemistry: molecular biology and microbiology
Vector, per se
435325, C12N 1563
Patent
active
059856556
ABSTRACT:
A vector particle (e.g., a retroviral vector particle) containing a chimeric envelope includes a receptor binding region that binds to a receptor of a target cell. The receptor of the target cell is other than the amphotropic cell receptor. The receptor binding region may be a receptor binding region of a human virus. A portion of the envelope gene may be deleted and the deleted portion is replaced with another receptor binding region or ligand. Such vector particles are targetable to a desired target cell or tissue, and may be administered directly to the desired target cell or tissue as part of a gene therapy procedure, or administered directly into the patient.
REFERENCES:
patent: 5328470 (1994-07-01), Nabel et al.
patent: 5354674 (1994-10-01), Hodgson
patent: 5512421 (1996-04-01), Burns et al.
patent: 5591624 (1997-01-01), Barber et al.
Goud et al. Virology. vol. 163, pp. 251-254, 1988.
Maddon et al. Cell. vol. 47, pp. 333-348, 1986.
Jolly, D. Cancer Gene Therapy. vol. 1, No. 1, pp. 51-64, 1994.
Barinaga, M. Science 1994. vol. 266 p. 1326.
Marshall, E. 1995 Science vol. 269, pp. 1050-1055.
Crystal, R. 1995 Science vol. 270 pp. 404-410.
Orkin, S.H. et al. 1995 Report and Recommendations of the Panel to Assess the NIH investment in Research on Gene Therapy. Dec. 1995. NIH Reports.
Bender, et al., J. Virol., vol. 61, No. 5, pp. 1639-1646 (1987).
Miller, et al., Biotechniques, vol. 7, No. 9, pp. 980-990 (1989).
Wu et al. JBC. vol. 262, No. 10, pp. 4429-4432, Apr. 5, 1987.
Wu et al. JBC.vol. 232, No. 29, pp. 14621-14624, Oct. 1988.
Anderson W. French
Baltrucki Leon F.
Mason James M.
Degen Nancy
Lillie Raymond J.
Olstein Elliot M.
The United States of America as represented by the Department of
Yucel Irem
LandOfFree
Targetable vector particles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targetable vector particles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targetable vector particles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1323588